Biblio

Eekers D, Roelofs E, Cubillos-Mesias M, et al. Data from: Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial. 2018. doi:10.17195/candat.2018.05.1.

• DOI
• Google Scholar

CanDat - 2018 Eekers - Data LGG .ods (157.14 KB) CanDat - 2018 Eekers - Data LGG .xlsx (183.07 KB)

Eekers DBP. Optimization of Brain and Head & Neck Radiotherapy. GROW - School for Oncology and Developmental Biology. 2018;Ph.D.:201. doi:10.17195/candat.2018.12.7.

• DOI
• Google Scholar

2018-Eekers-Thesis.pdf (5.47 MB) 2018-Eekers-Propositions.pdf (381.59 KB) 2018-Eekers-Thesis-Summary.pdf (318.74 KB)

Eekers DBP, Ven Lin 't, Deprez S, et al. The posterior cerebellum, a new organ at risk?. Clinical and Translational Radiation Oncology. 2018;8:22 - 26. doi:10.1016/j.ctro.2017.11.010.

• DOI
• Google Scholar

Eekers D, Roelofs E, Jelen U, et al. Data from: Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicenter in silico ROCOCO trial. 2016. doi:10.17195/candat.2016.04.2.

• DOI
• Google Scholar

Reymen B, van Gisbergen MW, Even AJG, et al. Data from: Nitroglycerin in non-small cell lung cancer: does it impact tumor hypoxia and tumor perfusion? A window-of-opportunity clinical trial. 2016. doi:10.17195/candat.2016.07.2.

• DOI
• Google Scholar

2017-08-28 Reymen - Nitro database HX-4 DCECT clean.zip (20.3 KB)

Even A, Hamming-Vrieze O, van Elmpt W, et al. Data from: Quantitative assessment of Zirconium-89 labeled cetuximab using PETCT imaging in patients with advanced head and neck cancer - a theragnostic approach. 2016. doi:10.17195/candat.2016.11.1.

• DOI
• Google Scholar

Even_P0037C0006I4475579.ZIP (97.26 MB) Even_P0037C0006I5879176.ZIP (131.21 MB) Even_P0037C0006I6042760.ZIP (115.71 MB) Even_P0037C0006I8991415.ZIP (101.03 MB)

Cheng Q, Roelofs E, Ramaekers B, et al. Data from: Development and Evaluation of an Online Three-Level Proton vs Photon Decision Support Prototype for Head and Neck Cancer - Comparison of Dose, Toxicity and Cost-Effectiveness. 2015. doi:10.17195/candat.2015.10.5.

• DOI
• Google Scholar

PRODECIS-HNC-results.xlsx (43.25 KB) PRODECIS-HNC-Figure-2.png (47.07 KB)

Even AJG, van der Stoep J, Zegers CML, et al. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. Radiother Oncol. 2015;116(2):281-6. doi:10.1016/j.radonc.2015.07.013.

• PubMed
• DOI
• Google Scholar